Current Report Filing (8-k)
28 August 2019 - 5:14PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 28, 2019
Kewaunee Scientific Corporation
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
0-5286
|
|
38-0715562
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
2700 West Front Street
Statesville, North Carolina
|
|
28677
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: 704-873-7202
N/A
(Former name or former address, if changed since last report.)
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock, $2.50 par value
|
|
KEQU
|
|
NASDAQ Global Market
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Item 7.01.
|
Regulation FD Disclosure
|
Kewaunee Scientific Corporation (the Company) has posted an investor presentation and related script to the Investor
Information section of the Companys website at http://www.kewaunee.com/About Us/Investor Information. The presentation and related script are attached hereto as Exhibits 99.1 and 99.2. The information included in Exhibits 99.1 and 99.2
is incorporated by reference in this Item 7.01, and is deemed to be furnished, not filed, pursuant to Item 7.01 of Form 8-K.
Certain statements made in the attached presentation and related script constitute forward-looking statements within the meaning
of the federal securities laws, including statements regarding the Companys future performance, as well as managements expectations, beliefs, intentions, plans, estimates or projections relating to the future. Management believes that
these forward-looking statements are reasonable. However, the Company cannot guarantee that its actual results will be consistent with the forward-looking statements and you should not place undue reliance on them. These statements are based on
current expectations and speak only as of the date they are made. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of future events, new information or otherwise. Important factors
regarding the Company that may cause results to differ from expectations are included in the Companys Annual Report on Form 10-K for the year ended April 30, 2019, under Item 1A. Risk
Factors, and in the Companys other filings with the SEC.
Item 9.01.
|
Financial Statements and Exhibits.
|
2
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
(Registrant)
Kewaunee Scientific Corporation
|
|
|
|
Date: August 28, 2019
|
|
|
|
/s/ Donald T. Gardner III
|
|
|
|
|
Donald T. Gardner III
|
|
|
|
|
Vice President, Finance and Chief Financial Officer
|
3
Kewaunee Scientific (NASDAQ:KEQU)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Kewaunee Scientific (NASDAQ:KEQU)
Historical Stock Chart
Von Jul 2023 bis Jul 2024